This grant by the National Institute on Alcohol Abuse and Alcoholism aims to explore new hypotheses on sensitivity and tolerance to alcohol. It seeks to establish a common framework for understanding the mechanisms behind tolerance development and progression to alcohol dependence. The Phased Innovation (R21/R33) mechanism allows for secondary data analysis and pilot studies in the R21 phase, with the opportunity to expand research in the R33 phase. Closing date for applications is May 07, 2021.
Opportunity ID: 300672
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-659 |
| Funding Opportunity Title: | Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 14, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2021 |
| Current Closing Date for Applications: | May 07, 2021 |
| Archive Date: | Jun 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities County governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Private institutions of higher education Special district governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The intent of this FOA is two-fold: (1) develop new hypotheses about key factors and pathways in sensitivity and tolerance to alcohol, and (2) develop a common framework of mechanisms underlying the development of tolerance and the progression to alcohol dependence. These objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, in which secondary data analysis or pilot studies can occur during the R21 phase, and research testing the hypotheses can be expanded in the R33 phase. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-659.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238254 | May 16, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260061 | May 16, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
300672 RR_SF424_2_0-2.0.pdf
300672 PHS398_CoverPageSupplement_4_0-4.0.pdf
300672 RR_OtherProjectInfo_1_4-1.4.pdf
300672 PerformanceSite_2_0-2.0.pdf
300672 RR_KeyPersonExpanded_2_0-2.0.pdf
300672 RR_Budget_1_4-1.4.pdf
300672 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
300672 RR_SubawardBudget30_1_4-1.4.pdf
300672 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
300672 RR_SF424_2_0-2.0.pdf
300672 PHS398_CoverPageSupplement_5_0-5.0.pdf
300672 RR_OtherProjectInfo_1_4-1.4.pdf
300672 PerformanceSite_2_0-2.0.pdf
300672 RR_KeyPersonExpanded_2_0-2.0.pdf
300672 RR_Budget_1_4-1.4.pdf
300672 PHS398_ResearchPlan_4_0-4.0.pdf
300672 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
300672 RR_SubawardBudget30_1_4-1.4.pdf
300672 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
